Myriad Genetics
MYGN
MYGN
284 hedge funds and large institutions have $3.48B invested in Myriad Genetics in 2018 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 93 increasing their positions, 83 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
284
Holders Change
+26
Holders Change %
+10.08%
% of All Funds
6.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
56
Increased
93
Reduced
83
Closed
28
Calls
$9.9M
Puts
$22.2M
Net Calls
-$12.3M
Net Calls Change
-$14.6M
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
$75.7M |
| 2 |
Millennium Management
New York
|
$44.5M |
| 3 |
Invesco
Atlanta,
Georgia
|
$65.8M |
| 4 |
Morgan Stanley
New York
|
$33.9M |
| 5 |
BlackRock
New York
|
$527M |
